May 18, 2022

Osmind publishes its first public benefit corporation report

Written by


Today, nearly one in five Americans, or 52.9 million people, live with a mental illness

Mental health conditions are one of the leading causes of death worldwide, especially among young adults, and are tied to shortening life spans. The mental health crisis was mounting long before the COVID-19 pandemic, but the crisis has only magnified since then. 

The global prevalence of anxiety and depression increased by 25% in the first year of the pandemic due to the unprecedented stress of social isolation, trauma, and loss that is only beginning to come to light now.

Today, there’s a movement among clinicians, patients, and researchers to accelerate new science that can help. The Osmind team is honored that our platform has become the leading health technology platform for advancing mental health interventions. 

In our first Osmind 2022 Public Benefit Corporation Report, we share details about our first two years in operation, 2020–2022, and the progress we’ve made in our commitment to openness, accountability, and the public good. We’ve made significant strides in the vision we set out to build. In the report, you’ll find more information about: 

How Osmind contributes to advances in real-world evidence and evidence-based practices in mental health. 

  • Osmind aims to advance science and clinical care through research studies and real-world evidence. For example, in early 2022, Osmind published the first of several groundbreaking research publications from our Osmind Real-world Ketamine Analyses (ORKA) initiative, the largest real-world analysis of ketamine infusion therapy for depression to date.
  • Osmind also enables clinicians to practice evidence-based medicine through our core electronic health record (EHR) technology. It’s the first and only EHR platform built by and for clinicians to capture research-grade data while optimizing for mental health workflows and patient care journeys. 

How Osmind champions patient accessibility and advocacy. 

  • The Osmind EHR is designed to meet the needs of patients in the digital age, with a patient app and an Osmind patient community that enables patients to share knowledge and support across 600+ mental health topics.
  • Osmind is a technology partner to the Ketamine Taskforce, which advocates for insurance coverage of ketamine treatments. 

How Osmind is building a multi-disciplinary and inclusive EHR platform. 

  • The Osmind EHR is accessible to a wide variety of providers, including all clinicians who support patients with mental health conditions. 
  • Osmind has built a team that cares deeply about mental health, including two psychiatrists on our executive leadership team, and an interdisciplinary team of five renowned Scientific Advisory Board members.

We continue to reinforce our commitment to helping solve the worldwide mental health crisis by serving more people living with moderate to severe mental health conditions and the clinicians who care for them — further advancing their therapeutic alliance. 

We will also continue to publish research and meaningful insights for the mental health field, ultimately enabling cutting-edge research in academia, the pharmaceutical industry, and life sciences organizations. As we move forward on the journey to fundamentally change mental healthcare, we invite you to follow along with our latest developments via our blog and on LinkedIn.

Discover what’s next in mental health care. Join the Psychiatry Tomorrow newsletter.

Share this

Related Blog Posts

If you, or someone you know, is in crisis or needs immediate assistance, please call 911 immediately. To talk to someone now, please call the National Suicide Prevention Lifeline at 1-800-273-8255.

Osmind Inc. © 2024 All Rights Reserved.